Impaired fatty acid oxidation is one of the key hallmarks of MAFLD, with excessive lipid uptake and enhanced SREBP1c-mediated de novo lipogenesis as two simultaneous drivers of liver steatosis [25]. The gene discussed is SREBF1; the disease is fatty liver disease.